Today, the National Bureau of Economics release a series of working paper presented at the last NBER Conf. on Economic Dimensions of Personalized & Precision Medicine. Among prestigious economist from Harvard, MIT, Kellogg School of Management …, we published a working paper on firms developing orphan drug and going public on NASDAQ.